(C024) Amundi MSCI China II EUR - Ratings and Ratios
Chinese, Stocks, Bonds, Equities
Description: C024 Amundi MSCI China II EUR
The Amundi MSCI China A II ETF EUR (XETRA:C024) is a Germany-domiciled ETF designed to track the performance of the Morningstar China TME NR USD Index. This index measures the total return of Chinese equities, focusing on companies listed in mainland China and Hong Kong. The ETF is categorized under China Equity, offering exposure to the Chinese stock market for European investors.
From a technical perspective, the ETF currently trades at €136.52, with a 20-day average volume of 1,974 shares. The SMA 20 (€137.78) and SMA 50 (€135.91) are slightly above the current price, while the SMA 200 (€126.21) indicates a longer-term upward trend. The Average True Range (ATR) of 1.69 reflects moderate volatility. With an AUM of €184.58 million, the fund maintains a moderate size, suggesting a balance between liquidity and diversification.
Looking ahead, the next three months are expected to see continued bullish momentum, supported by the upward trend in the SMA 20 and SMA 50. The ATR suggests manageable volatility, with price fluctuations likely remaining within a narrow range. The funds exposure to Chinese equities may benefit from improving economic indicators in China, such as industrial production and consumer spending growth, which are expected to stabilize in Q4 2023 and Q1 2024. However, external factors such as geopolitical tensions and global market sentiment could influence performance.
Additional Sources for C024 ETF
C024 ETF Overview
Market Cap in USD | 217m |
Category | China Equity |
TER | 0.25% |
IPO / Inception | 2023-03-10 |
C024 ETF Ratings
Growth Rating | -23.4 |
Fundamental | - |
Dividend Rating | 42.1 |
Rel. Strength | -12.2 |
Analysts | - |
Fair Price Momentum | 124.93 EUR |
Fair Price DCF | - |
C024 Dividends
Dividend Yield 12m | 2.34% |
Yield on Cost 5y | 2.07% |
Annual Growth 5y | 4.87% |
Payout Consistency | 94.5% |
Payout Ratio | % |
C024 Growth Ratios
Growth Correlation 3m | 48% |
Growth Correlation 12m | 18.4% |
Growth Correlation 5y | -71.9% |
CAGR 5y | -2.06% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -0.23 |
Alpha | 4.55 |
Beta | 0.285 |
Volatility | 14.68% |
Current Volume | 6.8k |
Average Volume 20d | 0.6k |
Stop Loss | 124 (-3.5%) |
As of July 09, 2025, the stock is trading at EUR 128.48 with a total of 6,801 shares traded.
Over the past week, the price has changed by +1.74%, over one month by +0.53%, over three months by +6.96% and over the past year by +14.45%.
Neither. Based on ValueRay´s Analyses, Amundi MSCI China II EUR is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -23.40 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C024 is around 124.93 EUR . This means that C024 is currently overvalued and has a potential downside of -2.76%.
Amundi MSCI China II EUR has no consensus analysts rating.
According to our own proprietary Forecast Model, C024 Amundi MSCI China II EUR will be worth about 137.4 in July 2026. The stock is currently trading at 128.48. This means that the stock has a potential upside of +6.97%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 137.4 | 7% |